Announcement PDF ASX Announcement 29 November 2024 Results of Annual General Meeting Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”), a company at the forefront of microbiome diagnostics & therapeutics, advises that its Annual General Meeting of Shareholders was held today at 11.00am AEST (Brisbane Time). The resolutions were voted in accordance with the Notice of Annual General Meeting previously advised to the Australian Securities Exchange (ASX), with all resolutions being passed on a poll. Resolution 4 (Approval of 10% Placement Facility) and Resolution 6 (Amendment to Constitution) were passed by a sufficient majority as special resolutions. Further information required by section 251AA(2) of the Corporations Act 2001 (Cth) is attached. - Ends - This announcement has been authorised for release by the Chair and Chief Executive Officer. For further information, please contact: Dr Luke Reid Chief Executive Officer luke.reid@microba.com Investor / Media Relations investor@microba.com https://ir.microba.com/welcome About Microba Life Sciences Limited Microba Life Sciences is a company at the forefront of microbiome diagnostics & therapeutics and are on a mission to improve human health. With world-leading technology for measuring the human gut microbiome, Microba is driving the discovery and development of novel therapeutics for major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. Through partnerships with leading organisations, Microba is powering the discovery of new relationships between the microbiome, health and disease for the development of new health solutions. For more information visit www.microba.com JOIN MICROBA’S INTERACTIVE INVESTOR HUB For more Company information and to engage with management by asking questions about Microba’s latest announcements and updates, visit ir.microba.com/welcome Microba Life Sciences Ltd | ABN 82 617 096 652 | L10, 324 Queen Street, Brisbane QLD 4000 Australia | 1300 974 621 Disclosure of Proxy Votes Automic GPO Box 5193, Sydney, NSW 2001 P 1300 288 664 (aus) or +61 (0)2 9698 5414 (world) F +61 (0)2 8583 3040 E hello@automic.com.au ABN 27 152 260 814 Microba Life Sciences Limited Annual General Meeting Friday, 29 November 2024 In accordance with section 251AA of the Corporations Act 2001, the following information is provided in relation to resolutions put to members at the meeting. Poll Results (if applicable) Proxy Votes Resolution Decided by Show of Hands (S) or Poll (P) Total Number of Proxy Votes exercisable by proxies validly appointed 1 Adoption of Remuneration Report P 210,230,691 2 Re-election of Mr Pasquale Rombola P 286,808,714 3 Re-election of Professor Ian Frazer P 286,893,250 4 Approval of 10% Placement Facility P 286,914,750 5 Renewal of the Microba Employee Incentive Plan and the issue of equity securities under the Microba Employee Incentive Plan P 281,935,250 6 Amendment to Constitution P 286,893,250 FOR AGAINST PROXY'S DISCRETION ABSTAIN 207,666,082 1,805,165 98.78% 0.86% 284,923,698 1,750,016 99.34% 0.61% 286,758,250 0 99.95% 0.00% 284,358,789 1,796,516 99.11% 0.63% 279,602,385 1,545,521 99.17% 0.55% 283,995,917 1,859,569 98.99% 0.65% 98,419 106,036 21,500 0 4,979,500 21,500 FOR AGAINST Results ABSTAIN 759,444 207,978,889 1,805,165 0.36% 99.14% 0.86% 135,000 285,649,283 1,750,016 0.05% 99.39% 0.61% 135,000 287,483,835 0 0.05% 100.00% 0.00% 759,445 285,708,819 1,796,516 0.26% 99.38% 0.62% 787,344 280,980,314 1,545,521 0.28% 99.45% 0.55% 1,037,764 285,624,266 1,859,569 0.36% 99.35% 0.65% OUTCOME 857,863 - 106,036 Carried 21,500 Carried 0 Carried 4,979,500 Carried 21,500 Carried